Alisol B
Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions. Alisol B also inhibited RANKL-induced expression of NFATc1 and c-Fos which are key transcription factors for osteoclastogenesis.
Product Specifications
CAS Number
18649-93-9
Purity
>98% (HPLC)
Solubility
DMSO:95 mg/mL (200.97 mM)
Smiles
[H][C@@]1 (OC1 (C) C) [C@@H] (O) C[C@@H] (C) C1=C2C[C@H] (O) [C@@]3 ([H]) [C@@]4 (C) CCC (=O) C (C) (C) [C@]4 ([H]) CC[C@]3 (C) [C@@]2 (C) CC1
Molecular Formula
C30H48O4
Molecular Weight
472.7
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL713351V 500 µL Each
Cyp4f5 Rat shRNA Lentiviral Particle (Locus ID 286905)
Sign In for Pricing
View Details 
bsm-62558R-PerCP-Cy5.5 100 µL
RPL26L1 Recombinant Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details